Alstodt Lance (CIK 0001756228)

Latest company ownership

Shares held
1,672,781
Last filed at
Oct 20, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 18, 2024 Mar 20, 2024 BioRestorative Therapies, Inc. CEO Sell 46.3 -17,633 -9.30% ✗ $24.5K
Sep 15, 2023 Sep 18, 2023 BioRestorative Therapies, Inc. CEO Buy 77.5 +2,200 1.17% ✗ $3.7K
Sep 13, 2023 Sep 13, 2023 BioRestorative Therapies, Inc. CEO Buy 60.0 +800 0.43% ✗ $1.2K
Sep 6, 2023 Sep 6, 2023 BioRestorative Therapies, Inc. CEO Buy 77.5 +2,887 1.57% ✗ $5.7K
Jul 25, 2023 Jul 25, 2023 BioRestorative Therapies, Inc. CEO Buy 78.8 +4,200 2.33% ✗ $10.2K
Mar 20, 2023 Mar 22, 2023 BioRestorative Therapies, Inc. CEO Sell 46.3 -6,729 -3.60% ✗ $19.6K
Feb 18, 2023 Feb 27, 2023 BioRestorative Therapies, Inc. CEO Sell 52.5 -374 -0.20% ✗ $1.1K
Feb 1, 2023 Feb 2, 2023 BioRestorative Therapies, Inc. CEO Buy 60.0 +400 0.21% ✗ $1.2K
Jan 27, 2023 Jan 30, 2023 BioRestorative Therapies, Inc. CEO Buy 55.0 +200 0.11% ✗ $602
Jan 20, 2023 Jan 24, 2023 BioRestorative Therapies, Inc. CEO Buy 55.0 +200 0.11% ✗ $627
Jan 18, 2023 Jan 20, 2023 BioRestorative Therapies, Inc. CEO Buy 60.0 +400 0.21% ✗ $1.2K
Jan 9, 2023 Jan 10, 2023 BioRestorative Therapies, Inc. CEO Buy 55.0 +100 0.05% ✗ $308
Dec 23, 2022 Dec 28, 2022 BioRestorative Therapies, Inc. CEO Buy 55.0 +300 0.16% ✗ $903
Dec 7, 2022 Dec 7, 2022 BioRestorative Therapies, Inc. CEO Buy 67.5 +1,800 0.98% ✗ $5.4K
Nov 18, 2022 Nov 21, 2022 BioRestorative Therapies, Inc. CEO Buy 67.5 +1,000 0.55% ✗ $2.9K
Sep 22, 2022 Sep 23, 2022 BioRestorative Therapies, Inc. CEO Buy 55.0 +200 0.11% ✗ $584
Jul 12, 2022 Jul 13, 2022 BioRestorative Therapies, Inc. CEO Buy 60.0 +700 0.38% ✗ $2.1K
Jun 30, 2022 Jul 1, 2022 BioRestorative Therapies, Inc. CEO Buy 67.5 +1,100 0.61% ✗ $3.4K
Jun 16, 2022 Jun 17, 2022 BioRestorative Therapies, Inc. CEO Buy 60.0 +600 0.33% ✗ $2.2K
Jun 15, 2022 Jun 15, 2022 BioRestorative Therapies, Inc. CEO Buy 60.0 +700 0.39% ✗ $2.6K
Jun 14, 2022 Jun 15, 2022 BioRestorative Therapies, Inc. CEO Buy 60.0 +500 0.28% ✗ $2K
Jun 13, 2022 Jun 14, 2022 BioRestorative Therapies, Inc. CEO Buy 55.0 +200 0.11% ✗ $790
Jun 8, 2022 Jun 9, 2022 BioRestorative Therapies, Inc. CEO Buy 55.0 +100 0.06% ✗ $428
Jun 1, 2022 Jun 3, 2022 BioRestorative Therapies, Inc. CEO Buy 55.0 +200 0.11% ✗ $920
May 26, 2022 May 27, 2022 BioRestorative Therapies, Inc. CEO Buy 77.5 +2,700 1.53% ✗ $9.5K
May 2, 2022 May 2, 2022 BioRestorative Therapies, Inc. CEO Buy 60.0 +400 0.23% ✗ $1.6K
Jan 24, 2022 Jan 24, 2022 BioRestorative Therapies, Inc. CEO Buy 67.5 +1,470 0.91% ✗ $5K
Jan 5, 2022 Jan 5, 2022 BioRestorative Therapies, Inc. CEO Buy 77.5 +2,000 1.25% ✗ $7.7K
Dec 1, 2021 Dec 2, 2021 BioRestorative Therapies, Inc. CEO Buy 67.5 +799 0.50% ✗ $4.4K
Nov 23, 2021 Nov 23, 2021 BioRestorative Therapies, Inc. CEO Buy 78.8 +2,500 1.60% ✗ $15K
Nov 22, 2021 Nov 22, 2021 BioRestorative Therapies, Inc. CEO Buy 60.0 +396 0.25% ✗ $2.5K
Nov 16, 2021 Nov 16, 2021 BioRestorative Therapies, Inc. CEO Buy 83.8 +4,500 2.97% ✗ $30.2K
Sep 9, 2019 Sep 10, 2019 BioRestorative Therapies, Inc. EVP and Chief Strategy Officer Buy 90.0 +20,000 66.67% ✗ $5.2K
Sep 5, 2019 Sep 6, 2019 BioRestorative Therapies, Inc. EVP and Chief Strategy Officer Buy 90.0 +10,000 50.00% ✗ $2.7K
Aug 27, 2019 Aug 27, 2019 BioRestorative Therapies, Inc. EVP and Chief Strategy Officer Buy 90.0 +10,000 100.00% ✗ $2.8K
Aug 21, 2019 Aug 22, 2019 BioRestorative Therapies, Inc. EVP and Chief Strategy Officer Buy 90.0 +10,000 100.00% ✗ $2.5K